UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | F | H | J | K | L | M | P | R | S | T | V | W
Number of items: 118.

A

Ah- See, ML; Burcombe, RJ; Daley, FM; Richman, P; Padhani, AR; Bentzen, SM; Fox, SB; ... Makris, A; + view all (2005) Evaluation of tunour microvessel density and pericyte coverge index following neoadjuvant chemotherapy in primary breast cancer. In: (pp. 42s-42s).

Ah-See, M; Makris, A; Taylor, NJ; Stirling, JJ; Daley, FM; Richman, P; Harris, A; ... Padhani, AR; + view all (2005) Correlating breast cancer and hypoxia status with MRI features. In: (pp. S205-).

Ah-See, M; Padhani, AR; Taylor, NJ; Harris, AL; Burcombe, RJ; Fox, SB; Richman, PI; ... Makris, M; + view all (2005) Lack of correlation between microvessel density & pericyte coverage index with breast cancer biposies & functional dynamic contrast-enhanced MRI-derived vascular parameters. In: (pp. S74-S75).

Ah-See, MW; Harris, AL; Burcombe, RJ; Fox, SB; Richman, PI; Daley, FM; Padhani, AR; ... Makris, A; + view all (2005) Evaluation of the effects of neoadjuvant chemotherapy on tumour microvessel density(MVD), pericyte coverage index(PCI), & vascular enodthelial growth factor(VEGF)in primary breast cancer. In: (pp. S224-).

Alonzi, R; Hoskin, P; (2005) Novel therapies in bladder cancer. CLINICAL ONCOLOGY , 17 (7) pp. 524-538.

Andy, S; (2005) My dad’s fight with lung cancer. Daily Express pp. 30-31.

Arkenau, H; Kubicka, S; Greil, R; Schmoll, H; Seufferlein, T; Greaven, U; Grothey, A; ... Porschen, R; + view all (2005) Infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus Capecitabine plus oxaliplatin (CAPOX) as first line treatment of metastatic colorectal carcinoma (MCRC): results of the safety and efficacy analysis. EJC SUPPL , 3 (2) 168 - 168.

Arkenau, H; Porschen, R; (2005) Adjuvante Therapie des Kolonkarzinoms. In: Schoelmerich, J and Schmiegel, W, (eds.) Leitfaden Kolorektales Karzinom. (pp. 175-183). Uni-Med.-Verlag: Bremen, Germany.

Arkenau, HT; Mussig, O; Buhr, T; Jend, HH; Porschen, R; (2005) Microangiopathic hemolytic anemia (MAHA) as paraneoplastic syndrome in metastasized signet ring cell carcinomas: Case reports and review of the literature. ZEITSCHRIFT FUR GASTROENTEROLOGIE , 43 (8) pp. 719-722. 10.1055/s-2005-858259.

Arkenau, HT; Rettig, K; Porschen, R; (2005) Adjuvant chemotherapy in curative resected colon carcinoma: 5-fluorouracil/leucovorin versus high-dose 5-fluorouracil 24-h infusion/leucovorin versus high-dose 5-fluorouracil 24-h infusion. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE , 20 (3) pp. 258-261. 10.1007/s00384-004-0657-6.

B

BBC, NB; (2005) Lung cancer scientist dies at 92. UNSPECIFIED

BBC, NO; (2005) 'Freeze therapy' for lung cancers. UNSPECIFIED

BBC, NO; (2005) Thalidomide slows cancer disease. UNSPECIFIED

BBC, NO; (2005) Warning to heed lung cancer signs. UNSPECIFIED

Begent, RHJ; Kerr, P; Parkinson, H; Reddington, F; Wilkinson, JM; (2005) NCRI Informatics initiative. UNSPECIFIED

Bentzen, SM; Atasoy, BM; Daley, FM; Dische, S; Richman, PI; Saunders, MI; Trott, KR; (2005) Epidermal growth factor receptor expression in pre-treatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomised controlled trial. Journal of Clinical Oncology , 23 (24) pp. 5560-5567. 10.1200/jco.2005.06.411.

Beresford, M; Ah-See M L, T; N J, S; J J, M; A, DJA; Leach, MO; Padhani, AR; (2005) Inter-and intra-observer variability of DCE-MRI in breast cancer. In:

Beresford, M; Glynne-Jones, R; Richman, P; Makris, A; Mawdsley, S; Stott, D; Harrison, M; ... Harrison, RA; + view all (2005) The reliability of lymph-node staging in rectal cancer after preoperative chemoradiotherapy. CLINICAL ONCOLOGY , 17 (6) pp. 448-455.

Beresford, M; Padhani, AR; Goh, V; Makris, A; (2005) Imaging breast cancer response during neoadjuvant systemic therapy. Expert Review of Anticancer Therapy , 5 (5) pp. 893-905.

Beresford, MJ; Ah-See, M; Daley, F; Richman, P; Harris, A; Makris, A; (2005) The role of the angiogenic marker, endoglin, as a predictor of response to neoadjuvant chemotherapy in primary bresat cancer. In: (pp. S59-S59).

Beresford, MJ; Ah-See, ML; Burcombe, R; Dixon, J; Ostler, P; Harrsion, M; Pittam, R; ... A, ; + view all (2005) Do pre-treatment haemaglobin levels predicct for response to neoadjuvant chemotherapy in breast cancer? In: (pp. 80s-80).

Beresford, MJ; Makris, A; Taylor, NJ; Stirling, JJ; Ah-See, M; d'Arcy, JA; Collins, D; (2005) Observer variability in dynamic contrast-enhanced MRI when used for prediction of response to neoadjuvant chemotherapy in primary breast cancer. In: (pp. S206-).

Bilioni, A.; (2005) DNA binding specificities and transcriptional activity of mirror, an Iroquois transcription factor in Drosophila melanogaster. Doctoral thesis , University of London. Green open access
file

Bower, M; Powles, T; Stebbing, J; Thirlwell, C; (2005) Potential antiretroviral drug interactions with cyclophosphamide, doxorubicin, and etoposide. J CLIN ONCOL , 23 (6) 1328 - 1329. 10.1200/JCO.2005.05.128.

Braithwaite, D; Sutton, S; Mackay, J; Stein, J; Emery, J; (2005) Development of a risk assessment tool for women with a family history of breast cancer. Cancer Detection and Prevention , 29 (5) pp. 433-439.

Braybrooke, JP; Slade, A; Deplanque, G; Harrop, R; Madhusudan, S; Forster, MD; Gibson, R; ... Harris, AL; + view all (2005) Phase I study of MetXia-P450 gene therapy and oral cyclophosphamide for patients with advanced breast cancer or melanoma. CLINICAL CANCER RESEARCH , 11 (4) pp. 1512-1520. 10.1158/1078-0432.CCR-04-0155.

Brooks, S; Bownes, P; Lowe, G; Bryant, L; Hoskin, PJ; (2005) Cervical brachytherapy utilizing ring applicator: comparison of standard and conformal loading. International Journal of Radiation Oncology Biology Physics , 63 (3) pp. 934-939.

Buchmueller, KL; Taherbhai, Z; Howard, CM; Bailey, SL; Nguyen, B; O'Hare, C; Hochhauser, D; ... Lee, M; + view all (2005) Design of a hairpin polyamide, ZT65B, for targeting the inverted CCAAT box (ICB) site in the multildrug resistant (MDR1) gene. CHEMBIOCHEM , 6 (12) 2305 - 2311. 10.1002/cbic.200500179.

Burcombe, RJ; Makris, A; Richman, PI; Daley, FM; Noble, S; Pittam, M; Wright, D; ... Wilson, GD; + view all (2005) Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer. British Journal of Cancer , 92 (1) pp. 147-155.

C

Calvert, H; Twelves, C; Ranson, M; Anthoney, A; Plummer, R; Fettner, S; Dayaram, B; ... Rakhit, A; + view all (2005) The effect of erlotinib on CYP3A4 activity, as quantified by the erythromycin breath test and oral midazolam kinetics in cancer patients: Preliminary results. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 210S - 210S). AMER SOC CLINICAL ONCOLOGY

Capponcelli, S; Pedrini, E; Cerone, MA; Corti, V; Fontanesi, S; Alessio, M; Bachi, A; ... Sangiorgi, L; + view all (2005) Evaluation of the molecular mechanisms involved in the gain of function of a Li-Fraumeni TP53 mutation. Hum Mutat , 26 (2) pp. 94-103. 10.1002/humu.20192.

Cerone, MA; Autexier, C; Londoño-Vallejo, JA; Bacchetti, S; (2005) A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT. Oncogene , 24 (53) pp. 7893-7901. 10.1038/sj.onc.1208934.

Cerone, MA; Ward, RJ; Londoño-Vallejo, JA; Autexier, C; (2005) Telomerase RNA mutated in autosomal dyskeratosis congenita reconstitutes a weakly active telomerase enzyme defective in telomere elongation. Cell Cycle , 4 (4) pp. 585-589.

Chang, JC; Hisenback, SG; Yee, D; Tsimelzon, A; Harrison, M; Gutierrez, CM; Elledge, RM; ... A, ; + view all (2005) Gene expression profiles as predictors of response to neoadjuvant taxotere and adriamycin/cyroxan:a propsective randomized trial in breast cancers. In: (pp. S31-S31).

Chester, KA; Baker, M; Mayer, A; (2005) Overcoming the immunologic response to foreign enzymes in cancer therapy. Expert Rev Clin Immunol , 1 (4) pp. 549-559. 10.1586/1744666X.1.4.549.

Cleator, SJ; Makris, A; Ashley, SE; Lal, R; Powles, TJ; (2005) Good clinical response of breast cancers to neoadjuvant chemoendocrine therapy is associated with improved overall survival. Annals of Oncology , 16 (2) pp. 267-272.

Coelho, JJ; Arnold, A; Nayler, J; Tischkowitz, M; Mackay, J; (2005) An assessment of the efficacy of cancer genetic counselling using real-time videoconferencing technology (telemedicine) compared to face-to-face consultations. European Journal of Cancer , 41 (15) pp. 2257-2261.

Corrie, PG; Shaw, J; Spanswick, VJ; Sehmbi, R; Jonson, A; Mayer, A; Bulusu, R; ... Cree, IA; + view all (2005) Phase I trial combining gemcitabine and treosulfan in advanced cutaneous and uveal melanoma patients. British Journal of Cancer , 92 (11) pp. 1997-2003.

Cutillas, PR; Geering, B; Waterfield, MD; Vanhaesebroeck, B; (2005) Quantification of gel-separated proteins and their phosphorylation sites by LC-MS using unlabeled internal standards: analysis of phosphoprotein dynamics in a B cell lymphoma cell line. Mol Cell Proteomics , 4 (8) pp. 1038-1051. 10.1074/mcp.M500078-MCP200.

D

Daniell, K; Stewart, M; Madsen, E; Le, M; Handl, H; Brooks, N; Kiakos, K; ... Lee, M; + view all (2005) Design, synthesis, and biological evaluation of achiral analogs of duocarmycin SA. BIOORG MED CHEM LETT , 15 (1) 177 - 180. 10.1016/j.bmcl.2004.10.021.

Daniell, K; Stewart, M; Madsen, E; Le, M; Handl, H; Brooks, N; Kiakos, K; ... Lee, M; + view all (2005) Design, synthesis, and biological evaluation of achiral analogs of duocarmycin SA. Bioorg Med Chem Lett , 15 (1) pp. 177-180. 10.1016/j.bmcl.2004.10.021.

Dearling, JLJ; Qureshi, U; Begent, RHJ; Pedley, RB; (2005) Radioimmunotherapy Combined with Anti-Hypoxia Therapy 2DG Results in Reduction of Therapeutic Efficacy. In: (pp. S48-S48). SPRINGER

Dearling, JLJ; Qureshi, U; Whiting, S; Boxer, GM; Begent, RHJ; Pedley, RB; (2005) Analysis of Antibody Distribution Reveals Higher Uptake in Peripheral Intrahepatic Deposits Than Central Deposits. In: (pp. S83-S83). SPRINGER

Deborah, H; (2005) I haven’t smoked for 23 years yet now I face the serves-you-right stigma of this forgotten disease. Evening Standard pp. 27-28.

F

Francis, R.J.; (2005) Antibody directed enzyme prodrug therapy - a mechanistic approach. Doctoral thesis , University of London. Green open access
file

H

Hartley, JA; Hochhauser, D; Lee, M; Howard, PW; Thurston, DE; (2005) DNA targeting with PBD and polyamide-based agents. In: CLINICAL CANCER RESEARCH. (pp. 9176S - 9176S). AMER ASSOC CANCER RESEARCH

Hoskin, PJ; (2005) Palliative radiotherapy for non-small-cell lung cancer: Which dose? ELSEVIER SCIENCE LONDON, 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND

Hoskin, PJ; (2005) Radioisotopes for metastatic bone pain. LANCET LTD, 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND

Hoskin, PJ; (2005) Evaluation and mangement of the patient with bone metastases at presentation. In: Claude, JE and Rodolfo, CE and Lawrence, CE and Robert, CE and Gerard, S, (eds.) Textbook of Bone Metastases. (pp. 545-554). John Wiley & Sons

Hoskin, PJ; (2005) Overview of treatment.Cancer Pain. In: Stephen, MMK, (ed.) Wall & Melzac's Textbook of Pain. Churchill Livingstone

Hoskin, PJ; Ahmedzai, S; Muers, MF; (2005) Assessment and management of respiratory symptoms of malignant disease. In: Ahmedzai, S and Muers, MF, (eds.) Supportive care in respiratory disease. (pp. 463-486). Oxford University Press

Hoskin, PJ; Smith, P; Maughan, TS; Gilson, D; Vernon, C; Syndikus, I; Linch, DC; (2005) Long-term results of a randomised trial of involved field radiotherapy vs extended field radiotherapy in stage I and II Hodgkin lymphoma. Clinical Oncology , 17 (1) pp. 47-53. 10.1016/j.clon.2004.07.004.

J

Jonathan, C-B; (2005) Freezing used to kill cancer cells. The Sunday Times

K

Kelly, CMA; Lee, SM; Steele, JP; (2005) Neoadjuvant chemotherapy for non-small cell lung cancer. In: Andrew, M, (ed.) Key Advances in Lung Cancer. (pp. 67-74). Aesculapius Medical Press: London, San Franscisco and Sydney.

Kim, J.B.; (2005) Development of a fully "humanized" xenograft model of breast cancer. Doctoral thesis , University of London. Green open access
file

Kim, JB; Price, RK; Stein, RC; O'Hare, MJ; (2005) Risks of the complementary medicine Rhodiola rosea in breast cancer. In: (pp. 3048S-3049S).

Kim, JB; Price, RK; Stein, RC; O'Hare, MJ; (2005) The risks of complementary medicine use (Rhodiola rosea) in breast cancer. In: (pp. 2698S-2698S).

Kim, JB; Stein, RC; O'Hare, MJ; (2005) Development of a fully "humanized" xenograft model of breast cancer - New ideas for the development of pre-clinical prevention models. International Journal of Cancer Prevention , 2 (2) pp. 87-107.

Kogelberg, H; Tolner, B; Lowdell, M; Qureshi, U; Robson, M; Dearling, JL; Pedley, RB; ... Chester, KA; + view all (2005) Mechansims of clearance of the antibody-directed enzyme prodrug therapeutic, the mannosylated MFE-CP. In: (Proceedings) NCRI Cancer Conference Proceedings.

Kotecha, M; O'Hare, C; Wells, G; Howard, P; Thurston, D; Mantovani, R; Hartley, JA; (2005) Inhibition of DNA binding of the transcription factor complex NF-Y by a pyrrolobenzodiazepine-polyamide conjugate. In: CLINICAL CANCER RESEARCH. (pp. 9016S - 9016S). AMER ASSOC CANCER RESEARCH

Krause, M; Wohlfarth, J; Georgi, B; Pimentel, N; Dorner, D; Zips, D; Eicheler, W; ... Baumann, M; + view all (2005) Low-dose hyperradiosensitivity of human glioblastoma cell lines in vitro does not translate into improved outcome of ultrafractionated radiotherapy in vivo. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY , 81 (10) pp. 751-758.

Kristeleit, R; Fong, P; Aherne, GW; de Bono, J; (2005) Histone deacetylase inhibitors: emerging anticancer therapeutic agents? Clin Lung Cancer , 7 Supp S19-S30.

L

Lankester, K.J.; (2005) Magnetic resonance imaging and the development of vascular targeted treatments for cancer. Doctoral thesis , University of London. Green open access
file

M

Macbeth, F; Stephens, R; Hoskin, P; (2005) Radiation dose in spinal cord compression. UNSPECIFIED

Makris, A; (2005) Report on the 9th International conference on primary therapy of early breast cancer. (Breast Cancer Forum , pp. pp. 2-6 ).

Makris, A; (2005) Tamoxifen and exemestane:to switch or not to switch? UNSPECIFIED

Makris, A; Hisenbeck, SG; Yee, D; Osborne, KC; Elledge, RM; Harrison, M; Ostler, PJ; ... Chang, JC; + view all (2005) A prospective randomized multicenter gene expression study of docetaxel vs doxorubicin/cyclophosphamide preoperative trial in primary breast cancers. In: (pp. 14S-14S).

Marelli, L; Stigliano, R; Triantos, C; Senzolo, M; Cholongitas, E; Davies, N; Tibballs, J; ... Burroughs, AK; + view all (2005) Transarterial therapy for hepatocellular carcinoma (HCC) in cirrhosis: Is embolisation as effective as chemoembolisation? Systematic review of cohort and randomized studies. In: (Proceedings) 56th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases. (pp. 384A-384A). JOHN WILEY & SONS INC

Marie-Egyptienne, DT; Cerone, MA; Londoño-Vallejo, JA; Autexier, C; (2005) A human-Tetrahymena pseudoknot chimeric telomerase RNA reconstitutes a nonprocessive enzyme in vitro that is defective in telomere elongation. Nucleic Acids Res , 33 (17) pp. 5446-5457. 10.1093/nar/gki848.

Mawdsley, S; Glynne-Jones, R; Grainger, J; Richman, P; Makris, A; Harrison, M; Ashford, R; ... Wallace, M; + view all (2005) Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival? International Journal of Radiation Oncology Biology Physics , 63 (3) pp. 745-752.

McTiernan, A; Meyer, T; Michelagnoli, MP; Lewis, I; Whelan, JS; (2005) A phase I/II study of doxorubicin, ifosfamide, etoposide and interval methotrexate in patients with poor prognosis osteosarcoma. Pediatric Blood and Cancer , 46 (3) pp. 345-350.

Mulholland, PJ; Thirlwell, C; Brock, CS; Newlands, ES; (2005) Emerging targeted treatments for malignant glioma. Expert Opin Emerg Drugs , 10 (4) pp. 845-854. 10.1517/14728214.10.4.845.

P

Padhani, AR; Ah-See, ML; Makris, A; (2005) MRI in the detection and management of breast cancer. Expert review of anticancer therapy , 5 (2) pp. 239-252.

Padhani, AR; Ah-See, ML; Taylor, NJ; Stirling, JJ; Daley, FM; Richamn, PI; d'Arcy, JA; ... Makris, A; + view all (2005) MRI correlates of tumour grade and hypoxia status in human breast cancer. In:

Parker, LL; Anderson, FM; O'Hare, CC; Lacy, SM; Bingham, JP; Robins, DJ; Hartley, JA; (2005) Synthesis of novel DNA cross-linking antitumour agents based on polyazamacrocycles. BIOORGAN MED CHEM , 13 (7) 2389 - 2395. 10.1016/j.bmc.2005.01.055.

Peleg, M; Steele, R; Thomson, R; Patkar, V; Rose, T; Fox, J; (2005) Open-source publishing of medical knowledge for creation of computer-interpretable guidelines. In: Miksch, S and Hunter, J and Keravnou, E, (eds.) ARTIFICIAL INTELLIGENCE IN MEDICINE, PROCEEDINGS. (pp. 156 - 160). SPRINGER-VERLAG BERLIN

Peltenburg, LTC; de Bruin, EC; Meersma, D; Smit, NPM; Schrier, PI; Medema, JP; (2005) Expression and function of the apoptosis effector Apaf-1 in melanoma. Cell Death Differ , 12 (6) pp. 678-679. 10.1038/sj.cdd.4401630.

Perkins, SJ; Gilbert, HE; Lee, YC; Sun, ZF; P, B; (2005) Relating small angle scattering and analytical ultracentrifugation in multidomain proteins. In: Scott, DJ and Harding, SE and Rowe, AJ, (eds.) Modern Analytical Ultracentrifugation: Techniques and Method. (pp. 291-319). Royal Society of Chemistry: London,UK.

Plummer, R; Middleton, M; Wilson, R; Jones, C; Evans, J; Robson, L; Steinfeldt, H; ... Calvert, AH; + view all (2005) First in human phase I trial of the PARP inhibitor AG-014699 with temozolomide (TMZ) in patients (pts) with advanced solid tumors. JOURNAL OF CLINICAL ONCOLOGY , 23 (16) 208S - 208S.

Pluzanska, A; Mainwaring, P; Cassidy, J; Utracka-Hutka, B; Zalucki, J; Glynne-Jones, R; Koralewski, P; ... Cunningham, D; + view all (2005) Final results of a randomized phase III study evaluating the addition of oxaliplatin first line to 5-FU followed by irinotecan at progression in advanced colorectal cancer (LIFE study). In: (Proceedings) 41st Annual Meeting of the American-Society-of-Clinical-Oncology. (pp. 250S-250S). AMER SOC CLINICAL ONCOLOGY

Pors, K; Phillips, RM; Hartley, JA; Patterson, LH; (2005) N-oxides of alkylating anthraquinones as hypoxia-targeting prodrugs. In: CLINICAL CANCER RESEARCH. (pp. 9053S - 9053S). AMER ASSOC CANCER RESEARCH

Price, CA; Lingerfelt, BM; Handl, HL; Kiakos, K; Hartley, JA; Lee, M; (2005) Sequence specific recognition of DNA by tailor-made hairpin conjugates of achiral seco-cyclopropaneindoline-2-benzofurancarboxamide and pyrrole-imidazole polyamides. Bioorg Med Chem Lett , 15 (12) pp. 3151-3156. 10.1016/j.bmcl.2005.04.006.

Pritchard-Jones, K; Spendlove, I; Wilton, C; Whelan, J; Weeden, S; Lewis, I; Hale, J; ... Durrant, LG; + view all (2005) Immune responses to the 105AD7 human anti-idiotypic vaccine after intensive chemotherapy, for osteosarcoma. British Journal of Cancer , 92 (8) pp. 1358-1365. 10.1038/sj.bjc.6602500.

R

Rades, D; Stalpers, LJA; Veninga, T; Hoskin, PJ; (2005) Spinal reirradiation after short-course RT for metastatic spinal cord compression. International Journal of Radiation Oncology Biology Physics , 63 (3) pp. 872-875.

Rades, D; Stalpers, LJA; Veninga, T; Schulte, R; Hoskin, PJ; Alberti, W; (2005) Effectiveness and toxicity of reirradiation (Re-RT) for metastatic spinal cord compression (MSCC). STRAHLENTHERAPIE UND ONKOLOGIE , 181 (9) pp. 595-600.

Rades, D; Stalpers, LJA; Veninga, T; Schulte, R; Hoskin, PJ; Obralic, N; Bajrovic, A; ... Schild, SE; + view all (2005) Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. Journal of Clinical Oncology , 23 (15) pp. 3366-3376.

Raja, FA; Bridgewater, JA; (2005) Survival following first line fluorouracil single agent therapy for advanced colarectal cancer in a cancer unit practice in the United Kingdom (UK). In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 274S - 274S). AMER SOC CLINICAL ONCOLOGY

Ravn, P; Thornton, A; Chester, KA; Pedley, B; Davidson, B; Winslet, M; Ogunbiyi, O; ... Meyer, T; + view all (2005) In situ selection of single chain antibodies by ex vivo perfusion of tumour-bearing human organs with phage display antibody libraries. In: (Proceedings) NCRI Cancer Conference Proceedings.

Robertson, JFR; Come, SE; Jones, SE; Beex, L; Kaufmann, M; Makris, A; Nortier, JWR; ... Rutqvist, LE; + view all (2005) Endocrine treatment options for advanced breast cancer - the role of fulvestrant. EUROPEAN JOURNAL OF CANCER , 41 (3) pp. 346-356.

Roos, DE; Turner, SL; O'Brien, PC; Smith, JG; Spry, NA; Burmeister, BH; Hoskin, PJ; (2005) Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05). Radiotherapy & Oncology , 75 (1) pp. 54-63.

S

Sainz-Pastor, N; Tolner, B; Huhalov, A; Kogelberg, H; Begent, RHJ; Chester, KA; (2005) Expression and purification of recombinant carcinoembryonic antigen frm the yeast Pichia pastoris. In: (Proceedings) NCRI Cancer Conference Proceedings.

Sainz-Pastor, N; Tolner, B; Huhalov, A; Kogelberg, H; Begent, RHJ; Chester, KA; (2005) Expression and purification of recombinant carcinoembryonic antigen from the yeast Pichia pastoris. In: (Proceedings) NCRI Cancer Conference Proceedings.

Sainz-Pastor, N; Tolner, B; Huhalov, A; Kogelberg, H; Lee, YC; Zhu, DL; Begent, RHJ; (2005) Deglycosylation to obtain stable and homogeneous Pichia pastoris-expressed N-A1 domains of carcinoembryonic antigen. International Journal of Biological Macromolecules , 39 (1 -3) pp. 141-150.

Sato, A; McNulty, L; Cox, K; Kim, S; Scott, A; Daniell, K; Summerville, K; ... Lee, M; + view all (2005) A novel class of in vivo active anticancer agents: achiral seco-amino- and seco-hydroxycyclopropylbenz[e]indolone (seco-CBI) analogues of the duocarmycins and CC-1065. J Med Chem , 48 (11) pp. 3903-3918. 10.1021/jm050179u.

Seddon, BM; Cassoni, AM; Galloway, MJ; Rees, JH; Whelan, JS; (2005) Fatal radiation myelopathy after high-dose busulfan and melphalan chemotherapy and radiotherapy for Ewing's sarcoma: A review of the literature and implications for practice. CLIN ONCOL-UK , 17 (5) 385 - 390. 10.1016/j.clon.2005.03.004.

Seddon, BM; McTiernan, AM; Michelagnoli, MP; Gabbie, S; Daw, S; Whelan, JS; (2005) High-dose ifosfamide in relapsed or progressive Ewing's sarcoma. In:

Sharma, SK; Bagshawe, KD; Begent, RHJ; (2005) Advances in antibody-directed enzyme prodrug therapy. Curr Opin Investig Drugs , 6 (6) pp. 611-615.

Sharma, SK; Griffin, N; Mayer, A; Tolner, B; Shahbakhti, H; Chester, KA; Begent, RHJ; (2005) Immunogenicity of a glycosylates antibody-enzyme fusion protien (MFECP1) in a phase I/II clinical study of ADEPT. In: (Proceedings) NCRI Cancer Conference Proceedings.

Sharma, SK; Pedley, RB; Meyer, A; Tolner, B; Griffin, N; Green, A; Boxer, GM; ... and Chester, KA; + view all (2005) Pharmacokinetics and pharmakodynamics of a glycosylated antibody-enzyme fusion protein for ADEPT. In: (Proceedings) Proceedings American Association for Cancer Research. (pp. 984-).

Short, S; Bourne, S; Martindale, C; Woodcock, M; Jackson, SP; (2005) DNA damage responses at low radiation doses. Radiation Research , 164 (3) pp. 292-302. 10.1667/RR3421.1.

Short, S; Buffa, F; Koritzinsky, M; Wouters, B; Bentzen, SM; (2005) Radiation induced changes in gene expression in human glioma cells. In:

Short, S; C, B; F, K; M, W; B, B; S, M; (2005) UNSPECIFIED In: (Proceedings) 6th Wolfsberg Conference on Molecular Radiation Biology/Oncology.

Short, S; Hoskin, P; Wong, W; (2005) Ovulation and increased FDG uptake on PET: Potential for a false-positive result. LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, PA 19106-3261 USA

Stebbing, J; Mandalia, S; Young, AM; Dhillon, T; Newshom-Davis, T; Thirlwell, C; Powles, T; ... Bower, M; + view all (2005) A new prognostic index for systemic AIDS-related lymphoma. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 844S - 844S). AMER SOC CLINICAL ONCOLOGY

Sujobert, P; Bardet, V; Cornillet-Lefebvre, P; Hayflick, JS; Prie, N; Verdier, F; Vanhaesebroeck, B; ... Bouscary, D; + view all (2005) Essential role for the p110 delta isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia. BLOOD , 106 (3) 1063 - 1066. 10.1128/blood-2004-08-3225.

T

Taherbhai, Z; Bailey, S; Sutterfield, A; Buchmueller, K; Nguyen, B; Kotecha, M; Hochhauser, D; ... Lee, M; + view all (2005) ZT-65B, a hairpin polyamide that binds to the inverted CCAAT box (ICB) site of the human multidrug resistant (MDR1) gene: Design, DNA binding, and biological studies. In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. (pp. U542 - U543). AMER CHEMICAL SOC

Taylor, NJ; Ah-See, ML; Stirling, JJ; d'Arcy, JA; Collins, DJ; Walker-Samuel, S; Leach, MO; ... Padhani, AR; + view all (2005) Pre-and post-chemotherapy comparisons of calculated rBV and rBF with signal intensity drop on T2* dynamic contrast-enhanced MRI of breast cancers. In: (pp. p. 91).

Thomas, MJ; Smith, A; Head, DH; Milne, L; Nicholls, A; Pearce, W; Vanhaesebroeck, B; ... Westwick, J; + view all (2005) Airway inflammation: chemokine-induced neutrophilia and the class I phosphoinositide 3-kinases. EUR J IMMUNOL , 35 (4) 1283 - 1291. 10.1002/eji.200425634.

Thomas, MJ; Smith, A; Head, DH; Milne, L; Nicholls, A; Pearce, W; Vanhaesebroeck, B; ... Westwick, J; + view all (2005) Airway inflammation: chemokine-induced neutrophilia and the class I phosphoinositide 3-kinases. EUROPEAN JOURNAL OF IMMUNOLOGY , 35 (4) pp. 1283-1291. 10.1002/eji.200425634.

Thomson, A; Mayne, N; Bamford, A; Daw, S; Whelan, J; Michelagnoli, M; (2005) Acute anthracycline-induced cardiotoxicity in children and adolescents treated for bone cancer. In:

Tolner, B; Taylorson, CJ; Kogelberg, H; Huhalov, S; Robson, L; Begent, RHJ; Chester, KA; (2005) A humanized ADEPT system using mutated human pancreatic ribonuclease. In: (Proceedings) NCRI Cancer Conference Proceedings.

Toth, JL; Trzupek, JD; Flores, LV; Kiakos, K; Hartley, JA; Pennington, WT; Lee, M; (2005) A novel achiral seco-amino-cyclopropylindoline (CI) analog of CC-1065 and the duocarmycins: design, synthesis and biological studies. Med Chem , 1 (1) pp. 13-19.

V

UNSPECIFIED (Ed). (2005) Novel implantable delivery system increases maximum tolerable doses of paclitaxel in mice. [Whole issue]. Proc Amer Assoc Cancer Res , 46

Venables, K; Miles, EA; Hoskin, PJ; Aird, EGA; (2005) Verification films: A study of the daily and weekly reproducibility of breast patient set-up in the START trial. Clinical Oncology , 17 (5) pp. 337-342.

Vigor, K; Lee, YC; Farrell, D; Huhalov, S; Robson, L; Begent, RHJ; Chester, KA; (2005) Antibody-nanoparticle complexation for hyperthermic treatment of tumours. In: (Proceedings) NCRI Cancer Conference Proceedings.

W

Westbury, C; Yarnold, J; (2005) Can a 'low risk' subgroup be identified in whom radiotherapy can safely be omitted after breast conservation surgery? In: MD, RL, (ed.) The effective management of breast cancer.

Whelan, JS; (2005) Osteosarcoma. In: Eden, OB and Barr, R and Bleyer, A and Whiteson, M, (eds.) Cancer and the Adolescent. Blackwell Publishing: Oxford.

Whelan, JS; McTiernan, AM; Weston, C; Ahrens, S; Grimer, R; Lewis, I; Douglas, C; ... Craft, A; + view all (2005) Differences in survival between Study Groups detected in an international randomised study: analysis of Eicess 92. In:

This list was generated on Sun May 20 01:52:15 2018 BST.